MARATTO

article · Natural Product Research

Aframomumlabdane, a new bislabdane diterpenoid from <i>Aframomum arundinaceum (</i> zingiberaceae)

Abstract

A previously undescribed bislabdane diterpenoid namely aframomumlabdane (<b>1</b>), was isolated from the seed of <i>Aframomum arundinaceum</i> together with seven known compounds (<b>2 </b>-<b> 8</b>). Their structures were established based on a comprehensive analysis of HR-ESI-MS, in conjunction with their 1D and 2D-NMR data. Compound <b>1</b> was evaluated for its cytotoxic activity against four cancer cell lines: A549, HepG2, SPC212 and DLD-1. The best activity was observed against SPC212 lung cancer cell line with an IC<sub>50</sub> value of 0.52 μM.

Research topics

  • Ginger and Zingiberaceae research
  • Mangiferin and Mango Extracts
  • Phytochemistry and biological activity of medicinal plants

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/14786419.2024.2372847

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.